A phase I study of SAR405838, a novel human double minute 2 (HDM2) antagonist, in patients with solid tumours
de Jonge, Maja, de Weger, Vincent A., Dickson, Mark A., Langenberg, Marlies, Le Cesne, Axel, Wagner, Andrew J., Hsu, Karl, Zheng, Wei, Macé, Sandrine, Tuffal, Gilles, Thomas, Koruth, Schellens, Jan H.Volume:
76
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/j.ejca.2017.02.005
Date:
May, 2017
File:
PDF, 464 KB
english, 2017